The global digital therapeutics (DTx) market is anticipated to grow at a considerable CAGR of 29.0% during the forecast period. The growing pervasiveness of chronic diseases is one of the prime factors affecting and driving the market. According to the World health organization (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Chronic diseases are having high levels of uncertainty and a new care lifestyle would support their behaviour. Through digital health technology, it will enhance prevention, diagnosis along with proper management of cardiovascular diseases that leads to getting better health outcomes.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/digital-therapeutics-market
The key players operating in the global digital therapeutics (DTx) market had been adopting strategies such as new launches to gain major market share. For instance, in July 2021, one of the software-enabled healthcare platform companies across the globe named Happify Health had introduced Ensemble, which is considered as first transdiagnostic prescription digital therapeutic in order to do the treatment of patients suffering from Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD).
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Product Type
o By Sales Channel
o By Application
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Otsuka Pharmaceutical Co., Ltd., Livongo Health, Omada Health, Inc., WellDoc, and Pear Therapeutics, Inc.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Digital Therapeutics (DTx) Market
By Product Type
- Software
- Device
By Sales Channel
- B2C
- B2B
By Application
- Preventive Applications
- Treatment/Care-related Applications
A full report of Digital Therapeutics (DTx) Market is available at: https://www.omrglobal.com/industry-reports/digital-therapeutics-market
Digital Therapeutics (DTx) Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Alex Therapeutics AB
- 2Morrow Inc.
- Akili Interactive Labs. Inc.
- Ayogo Health
- Canary Health
- Click Therapeutics, Inc.
- CogniFit
- Ginger
- HAPPIFY HEALTH
- Kaia Health
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
